anmelden
SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.04.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 24.04.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.04.19 | Novartis Neutral | UBS AG | |
| 24.04.19 | Alcon buy | Goldman Sachs Group Inc. | |
| 24.04.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 18.04.19 | Alcon Market Perform | BMO Capital Markets | |
| 18.04.19 | Roche buy | Jefferies & Company Inc. | |
| 18.04.19 | Roche Neutral | Credit Suisse Group | |
| 18.04.19 | Roche Hold | Deutsche Bank AG | |
| 17.04.19 | Roche buy | Goldman Sachs Group Inc. | |
| 17.04.19 | Roche Hold | Kepler Cheuvreux | |
| 17.04.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 17.04.19 | Roche Neutral | UBS AG | |
| 17.04.19 | Roche buy | Goldman Sachs Group Inc. | |
| 17.04.19 | Novartis buy | Jefferies & Company Inc. | |
| 16.04.19 | Novartis buy | Kepler Cheuvreux | |
| 12.04.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.04.19 | Roche buy | Goldman Sachs Group Inc. | |
| 10.04.19 | Alcon Neutral | UBS AG | |
| 10.04.19 | Novartis Underweight | Barclays Capital | |
| 10.04.19 | Novartis Underweight | Morgan Stanley | |
| 08.04.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 08.04.19 | Novartis Underweight | Barclays Capital | |
| 05.04.19 | Novartis Neutral | Credit Suisse Group | |
| 05.04.19 | Roche Hold | Deutsche Bank AG | |
| 05.04.19 | Novartis Hold | Deutsche Bank AG | |
| 03.04.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 03.04.19 | Roche overweight | JP Morgan Chase & Co. | |
| 02.04.19 | Roche overweight | JP Morgan Chase & Co. | |
| 29.03.19 | Roche overweight | JP Morgan Chase & Co. | |
| 27.03.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.03.19 | Novartis buy | Jefferies & Company Inc. | |
| 25.03.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.03.19 | Roche overweight | Barclays Capital | |
| 14.03.19 | Roche buy | Jefferies & Company Inc. | |
| 04.03.19 | Novartis Neutral | UBS AG | |
| 04.03.19 | Roche Neutral | UBS AG | |
| 26.02.19 | Roche Hold | Deutsche Bank AG | |
| 26.02.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 25.02.19 | Roche Neutral | Credit Suisse Group |
